Streamline Health Solutions In SEC Filings

Wyche T. Green III, Executive Chairman and Director of Streamline Health Solutions, reported disposals of company securities on 08/12/2025 pursuant to a merger. The Form 4 states the Merger Agreement dated May 29, 2025 became effective August 12, 2025, and each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The report shows dispositions and post-transaction beneficial ownership figures, and notes that certain restricted stock awards (11,199 shares) were converted into cash equal to their share count times the $5.34 Merger Consideration, less taxes.

The filing also reports treatment of outstanding warrants: Company warrants were canceled and either converted into a cash payment when the warrant exercise price was less than the $5.34 Merger Consideration or canceled for no consideration when the exercise price was equal to or greater than $5.34. The Form shows securities held in the account of 121G, LLC, which may be deemed beneficially owned by Mr. Green, and notes a 1-for-15 reverse split adjustment on October 4, 2024.

Benjamin L. Stilwill, who serves as President and CEO and is a director of Streamline Health Solutions (STRM), filed a Form 4 reporting dispositions of common stock on 08/12/2025 tied to a completed merger. Under the Merger Agreement, Merger Sub merged with and into the issuer and the issuer became a wholly owned subsidiary of Mist Holding Co.

At the effective time each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The filing also states that 13,712 restricted stock awards were canceled and converted into cash equal to the number of shares times the Merger Consideration, less applicable withholding taxes. The Form 4 notes inclusion of 3 shares owned by a spouse in the reported holdings.

Bryant J. Reeves, III, Chief Financial Officer of Streamline Health Solutions, Inc. (STRM), reported a disposition of common stock tied to the company's merger that became effective on 08/12/2025. Under the Merger Agreement, each share of common stock outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash per share.

The filing specifically notes that 9,499 restricted shares were included and were converted into cash equal to the number of shares multiplied by the Merger Consideration, less applicable withholding taxes. The Form 4 shows a reported amount of 13,515 shares listed in the beneficial ownership column following the reported transactions. The disclosure documents an insider cash settlement and the company's transition to being a wholly owned subsidiary of the acquirer.

Jonathan R. Phillips, a director of Streamline Health Solutions, reported dispositions of his holdings tied to the company’s merger effective 08/12/2025. Under the Merger Agreement each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The Form 4 shows 96,278 shares disposed directly and 4,833 shares held by his spouse as indirectly beneficial, totaling 101,111 shares converted.

The filing also reports treatment of Company warrants: warrants with an exercise price below the Merger Consideration were converted into a cash payment equal to the number of underlying shares multiplied by the excess of $5.34 over the warrant exercise price, producing cash for warrants covering 2,991 underlying shares; warrants with exercise prices equal to or above $5.34 were canceled without consideration. Reported amounts reflect a prior 1-for-15 reverse stock split.

Streamline Health Solutions, Inc. (STRM) completed a merger in which Mist Holding Co.'s wholly owned subsidiary merged into the issuer, with the issuer surviving as a wholly owned subsidiary of Parent. At the Effective Time each outstanding share of Streamline common stock was cancelled and converted into the right to receive $5.34 in cash per share. Reporting person Judith Starkey, identified as a director, reported the disposition of her holdings such that she beneficially owned 0 shares following the transaction; the Form 4 shows her prior reported holdings as 75,820 shares. The filing records the transaction date as 08/12/2025 and confirms the cash-out treatment of all outstanding common stock under the Merger Agreement.

Matthew Etheridge, a director of Streamline Health Solutions, reported dispositions tied to a merger that took effect on 08/12/2025. Under the Merger Agreement dated May 29, 2025, the company became a wholly owned subsidiary of Mist Holding Co., and each outstanding share of Streamline common stock was canceled and converted into the right to receive $5.34 in cash per share. The filing notes numbers were adjusted for a 1-for-15 reverse stock split effected on October 4, 2024.

The Form 4 shows Mr. Etheridge disposed of 30,876 common shares resulting in 0 common shares beneficially owned following the transaction. It also reports 61,403 underlying shares from Company warrants (exercise price listed as $5.85) that were canceled; warrants with exercise prices equal to or above the merger consideration were canceled for no consideration.

Streamline Health Solutions director Justin J. Ferayorni reported dispositions tied to a merger that became effective on 08/12/2025. Under the Merger Agreement, each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash, and the company became a wholly owned subsidiary of Mist Holding Co.

The Form 4 lists dispositions of common stock held directly and indirectly (reported as 78,416 shares direct and 92,294 shares indirect via Tamarack Advisers) and reports cancellation of 29,914 warrants with a $5.85 exercise price. The filing notes that warrants with exercise prices equal to or above the $5.34 Merger Consideration were canceled for no consideration and shows reported post-transaction beneficial ownership of the listed securities as 0.

On August 12, 2025, Mist Holding Co., parent of Hayes Management Consulting LLC d/b/a MDaudit, completed the acquisition of Streamline Health Solutions, Inc. under the parties' Merger Agreement. At the Effective Time each outstanding share of Streamline common stock was converted into the right to receive $5.34 per share in cash (subject to limited exceptions for treasury shares, Parent-held shares and perfected appraisal rights). Outstanding options and warrants with an exercise price below $5.34 were cashed out for the excess of the merger price over the exercise price; those with an exercise price equal to or above $5.34 were cancelled for no consideration. Unvested restricted stock awards were converted into cash equal to the number of underlying shares multiplied by $5.34, net of withholding.

Upon closing the Company became a wholly owned subsidiary of Parent. The Company terminated its Second Amended and Restated Loan and Security Agreement with Western Alliance Bank and repaid all loans, interest and related obligations. Trading in the Company’s shares was halted prior to the opening on August 12, 2025, the Company requested Nasdaq file Form 25 to delist the shares, and the Company intends to file Form 15 to deregister the shares and suspend reporting. All pre-closing directors and certain officers resigned; Ritesh Ramesh was appointed sole director and CEO and Nick Barnes was appointed CFO, Treasurer and Secretary. The Certificate of Incorporation and Bylaws were amended and restated and a joint press release was filed as Exhibit 99.1.

Streamline Health Solutions, Inc. submitted a Form 25 notifying removal of its common stock from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer's principal office and telephone number, cites Nasdaq's statement that it complied with applicable rules to file Form 25, and is signed by Jennifer Fainer, CDO Analyst, dated 2025-08-12.